AstraZeneca braced for hostile bid

Updated
PA
PA

%VIRTUAL-SkimlinksPromo%Speculation is mounting that US pharmaceutical giant Pfizer is set to make a hostile bid for AstraZeneca after its £63 billion takeover offer was spurned.

The UK company said the offer "substantially" undervalued the business, forcing Pfizer to consider its next move.

Advertisement